Search

Filters
Clear All
  • 7
  • 17

Phase

  • 1
  • 2
  • 5
  • 6
  • 10
  • 24
  • 1

Found 24 Breast Cancer trials

A listing of Breast Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

T
Tarah Ballinger, MD
18 years - 100 years
Female
What is the purpose of this study?The main purpose of this study is to learn more about how genetic ancestry affects treatment completion for patients who are diagnosed with breast cancer. THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients are not actively “recruited,” but …
 The Susan G Komen Tissue Bank at the IU Simon Cancer Center A Collection and Storage of Biological Specimens Intended for use in the Elucidation of Breast Carcinogenesis
M
Michele Cote
18 years - 100 years
Accepts healthy volunteer
All genders
Would you like to contribute to the fight against breast cancer?  You can help by donating a breast tissue sample during an event at the IU Melvin and Bren Comprehensive Cancer Center from 8 am to 2 pm on October 19th, 2024.  While the donation process takes only 60-90 minutes, …
E
Evan James Jordan
18 years - 100 years
All genders
What is the purpose of this study?The purpose of this study is to design, build, and test a mobile phone app called MOSAIC to address stress as it is experienced by breast cancer survivors in real time. THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent with most oncology trials, patients …
K
Kathy Miller, MD
16 years - 100 years
All genders
Phase 3
What is this study about?This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill …
N
Nawal Kassem
18 years - 100 years
All genders
Phase 3
What is the purpose of this study?The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the …
K
Kathy Miller, MD
18 years - 100 years
All genders
Phase 1/2
What is the purpose of this study?This phase I trial studies the side effects and best dose of vaccine therapy in treating patients with metastatic solid tumors. Vaccines made from antibodies and peptides combined with tumor cells may help the body build an effective immune response to kill tumor cells.THIS …
 ARE YOU A BREAST CANCER SURVIVOR?  Join Our Study and Help Researchers Learn More About Treating Cognitive Problems Attributed to Chemotherapy
B
Brenna McDonald
18 years - 100 years
Female
ARE YOU A BREAST CANCER SURVIVOR?  HAVE YOU NOTICED ANY PROBLEMS WITH YOUR COGNITIVE FUNCTION - MEMORY, ATTENTION, ABILITY TO MULTI-TASK - AFTER COMPLETING CHEMOTHERAPY? Researchers at Indiana University School of Medicine and the University of Pittsburgh are seeking volunteers to take part in a study looking at two telehealth-delivered therapies …
T
Tarah Ballinger, MD
18 years - 45 years
Female
Phase 2
What is the purpose of this study?This phase II trial tests whether low-dose aspirin can affect markers of inflammation in postpartum (after childbirth) patients with benign breast disease planning to have a breast biopsy. Chronic inflammation may increase the risk of postpartum related breast cancer. Low-dose aspirin is a non-steroidal …
K
Kathy Miller, MD
18 years or above
All genders
Phase 3
Interventional
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work inventing breast cancer from coming back (relapsing) in patients with high risk, HER2ve breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to ahemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it …
K
Kathy Miller, MD
18 years - 100 years
Female
The purpose of this study is to develop a repository of clinical data and outcomes, with and without corresponding specimens from individuals who have participated in TBCRC studies.
11 - 20 of 24